Mild cognitive impairment is associated with mild parkinsonian signs in a door-to-door study

Journal of Alzheimer's Disease

Volumn 22, Issue 3, 2010, Pages 1005-1013

  Israeli Korn, Simon D ^a   Massarwa, Magda ^a   Schechtman, Edna ^b   Strugatsky, Rosa ^a   Avni, Shiri ^c   Farrer, Lindsay A ^d   Friedland, Robert P ^e   Inzelberg, Rivka ^a,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d BOSTON UNIVERSITY   (United States)

^e University of Louisville School of Medicine   (United States)

Author keywords

Aging; Alzheimer's disease; mild cognitive impairment; mild parkinsonian signs; neuroepidemiology; risk factors

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRADYKINESIA; CONTROLLED STUDY; FOLLOW UP; HUMAN; INTERVIEW; ISRAEL; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NEUROLOGIC EXAMINATION; OBSERVATIONAL STUDY; PARKINSONISM; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RIGIDITY; RISK FACTOR; SCORING SYSTEM; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE;

EID: 78650644349     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-101230     Document Type: Article

References (48)

1. Louis ED, Bennett DA (2007) Mild Parkinsonian signs: An overview of an emerging concept. Mov Disord 22, 1681-1688.
2. Inzelberg R, Schechtman E, Abuful A, Masarwa M, Mazarib A, Strugatsky R, Farrer LA, Green RC, Friedland RP (2007) Education effects on cognitive function in a healthy aged Arab population. Int Psychogeriatr 19, 593-603.
3. Farrer LA, Friedland RP, Bowirrat A, Waraska K, Korczyn A, Baldwin CT (2003) Genetic and environmental epidemiology of Alzheimer's disease in arabs residing in Israel. J Mol Neurosci 20, 207-212.
4. Glik A, Masarwa M, Abuful A, Deeb A, Strugatsky R, Farrer LA, Friedland RP, Inzelberg R (2009) Essential tremor might be less frequent than Parkinson's disease in North Israel Arab villages. Mov Disord 24, 119-122.
5. Inzelberg R, Mazarib A, Masarwa M, Abuful A, Strugatsky R, Friedland RF (2006) Essential tremor prevalence is low in Arabic villages in Israel: door-to-door neurological examinations. J Neurol 253, 1557-1560.
6. Fahn S ER (1987) The UPDRSDevelopment Committee. Unified Parkinson's Disease Rating Scale, Macmillan Healthcare Information, Florham Park, NJ.
7. Louis ED, Schupf N, Manly J, Marder K, Tang MX, Mayeux R (2005) Association between mild parkinsonian signs and mild cognitive impairment in a community. Neurology 64, 1157-1161.
8. Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56, 33-39.
9. Davies A (1987) Epidemiology of Senile Dementia in Jerusalem. Brookdale Foundation, Jerusalem.
10. Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43, 2412-2414.
11. Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H, McDowell I (1997) Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 349, 1793-1796.
12. -(1994) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, American Psychiatric Association, Washington, DC.
13. -(1992) The ICD-10 Classification of Mental and Behavioural Disorders, World Health Organization, Geneva.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
15. Boyle PA, Wilson RS, Aggarwal NT, Arvanitakis Z, Kelly J, Bienias JL, Bennett DA (2005) Parkinsonian signs in subjects with mild cognitive impairment. Neurology 65, 1901-1906.
16. Louis ED, Tang MX, Schupf N, Mayeux R (2005) Functional correlates and prevalence ofmild parkinsonian signs in a community population of older people. Arch Neurol 62, 297-302.
17. Bennett DA, Beckett LA, Murray AM, Shannon KM, Goetz CG, Pilgrim DM, Evans DA (1996) Prevalence ofparkinsonian signs and associated mortality in a community population of older people. N Engl J Med 334, 71-76.
18. Louis ED, Luchsinger JA, Tang MX, Mayeux R (2003) Parkin- sonian signs in older people: prevalence and associations with smoking and coffee. Neurology 61, 24-28.
19. Prettyman R (1998) Extrapyramidal signs in cognitively intact elderly people. Age Ageing 27, 557-560.
20. Richards M, Stern Y, Mayeux R (1993) Subtle extrapyrami- dal signs can predict the development of dementia in elderly individuals. Neurology 43, 2184-2188.
21. Richards M, Stern Y, Mayeux R (1995) Subtle extrapyramidal signs and incident dementia: a follow-up analysis. Neurology 45, 1942.
22. Louis ED, Tang MX, Mayeux R (2004) Parkinsonian signs in older people in a community-based study: risk of incident dementia. ArchNeurol 61, 1273-1276.
23. Stern M (1978) The clinical characteristics ofParkinson's disease and parkinsonian syndromes: diagnosis and assessment, PMA.
24. Louis ED, Tang MX, Schupf N (2010) Mild parkinsonian signs are associated with increased risk ofdementia in a prospective, population-based study of elders. Mov Disord 25, 172-178.
25. Bennett DA, Shannon KM, Beckett LA, Goetz CG, Wilson RS (1997) Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology 49, 1580-1587.
26. Bennett DA, Shannon KM, Beckett LA, Wilson RS (1999) Dimensionality of parkinsonian signs in aging and Alzheimer's disease. J Gerontol A Biol Sci Med Sci 54, M191-196.
27. Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA (2003) Parkinsonianlike signs and risk of incident Alzheimer disease in older persons. ArchNeurol 60, 539-544.
28. Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA (2006) Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch Neurol 63, 17631769.
29. Israeli-Korn SD, Masarwa M, Schechtman E, Abuful A, Strugatsky R, Avni S, Farrer LA, Friedland RP, Inzelberg R (2010) Hypertension increases the probability of Alzheimer's disease and of mild cognitive impairment in an arab community in northern Israel. Neuroepidemiology 34, 99-105.
30. Richards M, Marder K, Cote L, Mayeux R (1994) Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination. Mov Disord 9, 89-91.
31. Portet F, Scarmeas N, Cosentino S, Helzner EP, Stern Y (2009) Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study. Arch Neurol 66, 1120-1126.
32. Bhadelia RA, Price LL, Tedesco KL, Scott T, Qiu WQ, Patz S, Folstein M, Rosenberg I, Caplan LR, Bergethon P (2009) Diffusion tensor imaging, white matter lesions, the corpus callosum, and gait in the elderly. Stroke 40, 3816-3820.
33. Srikanth V, Beare R, Blizzard L, Phan T, Stapleton J, Chen J, Callisaya M, Martin K, Reutens D (2009) Cerebral white matter lesions, gait, and the risk ofincident falls: a prospective population-based study. Stroke 40, 175-180.
34. Burns JM, Galvin JE, Roe CM, Morris JC, McKeel DW (2005) The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs. Neurology 64, 1397-1403.
35. Liu Y, Stern Y, Chun MR, Jacobs DM, Yau P, Goldman JE (1997) Pathological correlates of extrapyramidal signs in Alzheimer's disease. Ann Neurol 41, 368-374.
36. Schneider JA, Li JL, Li Y, Wilson RS, Kordower JH, Bennett DA (2006) Substantia nigra tangles are related to gait impairment in older persons. Ann Neurol 59, 166-173.
37. Gearing M, Levey AI, Mirra SS (1997) Diffuse plaques in the striatum in Alzheimer disease (AD): relationship to the striatal mosaic and selected neuropeptide markers. JNeuropathol Exp Neurol 56, 1363-1370.
38. Suva D, Favre I, Kraftsik R, Esteban M, Lobrinus A, Mik- lossy J (1999) Primary motor cortex involvement in Alzheimer disease. J Neuropathol Exp Neurol 58, 1125-1134.
39. Louis ED, Brickman AM, DeCarli C, Small SA, Marder K, SchupfN, Brown TR (2008) Quantitative brain measurements in community-dwelling elderly persons with mild parkinsoni- an signs. ArchNeurol 65, 1649-1654.
40. Bronge L, Wahlund LO (2007) White matter changes in dementia: does radiology matter? Br J Radiol 80 Spec No 2, S115-120.
41. de la Torre JC (2002) Alzheimer's disease: how does it start? J Alzheimers Dis 4, 497-512.
42. Geroldi C, Ferrucci L, Bandinelli S, Cavazzini C, Zanetti O, Guralnik JM, Frisoni GB (2003) Mild cognitive deterioration with subcortical features: prevalence, clinical characteristics, and association with cardiovascular risk factors in community-dwelling older persons (The InCHIANTI Study). JAm Geriatr Soc 51, 1064-1071.
43. Gorelick PB (2004) Risk factors for vascular dementia and Alzheimer disease. Stroke 35, 2620-2622.
44. Gorelick PB (2005) William M. Feinberg Lecture: Cognitive vitality and the role of stroke and cardiovascular disease risk factors. Stroke 36, 875-879.
45. Louis ED, Luchsinger JA (2006) History of vascular disease and mild parkinsonian signs in community-dwelling elderly individuals. Arch Neurol 63, 717-722.
46. Arvanitakis Z, Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA (2004) Diabetes mellitus and progression of rigidity and gait disturbance in older persons. Neurology 63, 996-1001.
47. Alzheimer's Disease International. In World Alzheimer Report 2009. Eds Prince MJ and Jackson J. ADI, London, 2009
48. Rozzini L, Chilovi BV, Bertoletti E, Conti M, Delrio I, Tra- bucchi M, Padovani A (2008) Mild parkinsonian signs and psycho-behavioral symptoms in subjects with mild cognitive impairment. Int Psychogeriatr 20, 86-95., London, 2009.